Brooks Houghton Investment Banking

Weak U.S. retail sales cast gloom over economy

U.S. retail sales fell for the first time in seven months in September, suggesting that manufacturing-led weakness could be spreading to the broader economy, keeping the door open for the

Read More

Bayer expects significant surge in number of U.S. glyphosate cases

Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides maker tries to

Read More

Bulgaria ready to sweeten its bid to win Volkswagen plant: lobby group

Bulgaria is ready to offer more incentives to Volkswagen to build a new plant in the country after the carmaker postponed a decision on building it in Turkey amid criticism

Read More

Kevin M. Halpin joins Brooks, Houghton & Company, Inc. - July 31, 2019

New York, NY Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that Kevin M. Halpin has joined the firms Investment Banking team as a Managing Director.

Read More
BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition - November 5, 2018

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets

Read More
BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Acquisition of Assets - October 11, 2018

Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto

Read More

Sale of Specialty Packaging Manufacturer

Purchase of an Office Products Company

Senior and Junior Debt Raise for a Steel Products Company

Lease Financing for the Subsidiary of an Aluminum Company

Equity Raise for a Luxury Hotel and Spa